跳至主要内容
临床试验/NCT01064726
NCT01064726已完成1 期

A Double Blind (3rd Party Open), 3-Way Crossover Study To Explore The Reproducibility Of Inflammatory Markers After Nasal Allergen Challenge In Subjects With Seasonal Allergic Rhinitis (Out Of Season) And The Effect Of A Single Dose Of Ibuprofen Or Fluticasone Propionate On The Allergen Response.

Pfizer1 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2009年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
Pfizer
入组人数
18
试验地点
1
主要终点
Nasal inflammatory markers

研究概览

简要总结

After a nasal allergen challenge it should be possible to measure markers of inflammation that may be useful to assess the properties of future drugs. If these markers are reproducible and impacted by the study drugs they could be useful for future drug development.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
19 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female subjects with seasonal allergic rhinitis (out of season).
  • Sensitive to ragweed skin prick test and screening nasal allergen challenge.

排除标准

  • Subjects with significant concomitant diseases.
  • Subjects with symptoms of allergic rhinitis in 2 weeks prior to screening.
  • Female subjects that are pregnant or nursing. Subjects with hypersensitivity to study drugs or allergen challenge.

研究组 & 干预措施

Ibuprofen

Experimental

干预措施: Ibuprofen (Drug)

Fluticasone propionate

Experimental

干预措施: Fluticasone propionate (Drug)

Placebo

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

Nasal inflammatory markers

时间窗: 8h 45 min post dose

Acoustic rhinometry

时间窗: 8h 45 min post dose

Nasal symptom scores

时间窗: 8h 45 min post dose

次要结局

  • Spirometry(8h 45 min post dose)

研究者

发起方
Pfizer
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验